Pancreatic Enzyme Replacement Therapy for Enterally Fed Patients With Cystic Fibrosis | Zendy

Nicolo Michele | Zendy; Stratton Kathleen W. | Zendy; Rooney Wanda | Zendy; Boullata Joseph | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Pancreatic Enzyme Replacement Therapy for Enterally Fed Patients With Cystic Fibrosis

Author(s) -

Nicolo Michele,

Stratton Kathleen W.,

Rooney Wanda,

Boullata Joseph

Publication year - 2013

Publication title -

nutrition in clinical practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.725

H-Index - 71

eISSN - 1941-2452

pISSN - 0884-5336

DOI - 10.1177/0884533613491786

Subject(s) - medicine , cystic fibrosis , pancreatic enzymes , enteral administration , parenteral nutrition , enzyme replacement therapy , feeding tube , pancreas , intensive care medicine , gastroenterology , surgery , disease

Administration of pancreatic enzymes (pancrelipase) to adult patients with cystic fibrosis when receiving enteral nutrition through a feeding tube is challenging. A number of techniques for preparing and administering the drug may result in complications that include feeding tube occlusion and inadequate enzyme delivery to the patient. A series of inpatient encounters is described.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research